The reveal · Research tools
EvidenceFlow
Systematic review and meta-analysis platform for literature screening, data extraction, and evidence synthesis
- 0community votes
- 0DR by Ahrefs no change since last check
Ahrefs Domain Rating rehearsed 16 Nov 2026, recast 30 Oct 2026.
Free platform for systematic reviews, meta-analysis, and literature screening with optional paid AI-assisted features for screening, extraction, and manuscript
The story

EvidenceFlow is an AI-powered evidence synthesis platform designed for researchers, clinicians, and bioinformaticians conducting systematic reviews and meta-analyses. The core platform is free and includes literature import from PubMed, Scopus, RIS and BibTeX, automated deduplication, manual and AI-assisted screening with blind dual review, structured data extraction, meta-analysis with fixed and random effects pooling, PRISMA 2020 flow diagram generation, and team collaboration features. Paid AI-assisted features include relevance scoring and screening prioritization, extraction auto-fill, and manuscript drafting. The platform supports omics data integration for GWAS and RNA-seq analysis, generates publication-ready forest and funnel plots, and exports results as PDF, Word, Excel, CSV, and JSON.
Set list
- Full-text screening with inclusion/exclusion criteria
- Automated data extraction with AI auto-fill
- Forest plots and funnel plots
- Literature import from PubMed, Scopus, RIS, BibTeX, CSV
Pricing
Pricing model: Freemium
Free: Core platform with literature import, manual screening, extraction, meta-analysis, PRISMA 2020 flow diagrams, omics dashboard, report export, team collaboration, and 50 free AI actions. AI Assistant: ₹399/month, cancel anytime, includes AI-assisted screening, AI relevance scoring, AI extractio
Follow EvidenceFlow to get an email when they post a milestone, ship a new product or add a demo video.
EvidenceFlow metrics
Reviews of evidenceflow.in's run: Ahrefs Domain Rating and Majestic link data, with the change since the last show.
- 0 Domain Rating no change since last check
- 0 Trust Flow no change since last check
- 22 Citation Flow no change since last check
- 11 Referring domains no change since last check
- 18 External backlinks no change since last check
Ahrefs Domain Rating rehearsed 16 Nov 2026, recast 30 Oct 2026. Majestic rehearsed 30 Oct 2026, recast 30 Oct 2026. Link credits: Majestic. Trust Flow, Citation Flow and Topical Trust Flow are trademarks of Majestic-12 Ltd.
EvidenceFlow: the venue online
Show the venue details
Source: the public RDAP record, checked 15 Nov 2026, 22:27 UTC.
- Domain age 2 months
- Registered
- Expires
- Registrar HOSTINGER operations, UAB
- DNSSEC Not signed
EvidenceFlow: the run since opening night
| Measure | At launch, then latest |
|---|---|
| Domain Rating (Ahrefs) | 0 to 0 no change since launch 30 Oct 2026, then 15 Nov 2026 |
| Trust Flow (Majestic) | 0 first measured 30 Oct 2026 |
| Referring domains (Majestic) | 11 first measured 30 Oct 2026 |
Day 17 since launch. Next receipt: day 30, 29 Nov 2026. A change here is a reading, not a claim about its cause; lots of things move these figures. Anything we do not measure is not shown.
Got a launch coming up?
Free tips from Unvero Launch for getting ready, launch day, the week after and what to do next.
- Get ready
- Launch day
- Week after
- Afterwards
Questions after the show
- What is EvidenceFlow?
- EvidenceFlow is an AI-assisted evidence synthesis platform for systematic reviews, meta-analysis, and omics research. It streamlines literature screening, structured data extraction, PRISMA 2020 reporting, and statistical analysis for researchers, clinicians, and bioinformaticians.
- Is EvidenceFlow free to use?
- The core platform is free with no time limit or seat restrictions, including literature import, manual screening, extraction, meta-analysis, PRISMA reporting, and reporting. AI-assisted screening, extraction auto-fill, and manuscript drafting are a paid upgrade at ₹399/month.
- How does AI screening work in EvidenceFlow?
- EvidenceFlow uses AI to prioritize studies based on your research question, PICO framework, and inclusion/exclusion criteria. Each study receives a suggested decision, confidence score, and explanation, while final screening decisions always remain under researcher control.
- Can I collaborate with multiple reviewers?
- Yes. EvidenceFlow supports multi-reviewer projects with role-based access, dual-reviewer screening, conflict detection, and an audit trail of every decision.
- What statistical models are supported?
- EvidenceFlow's meta-analysis engine supports both fixed-effect and random-effects pooling using DerSimonian–Laird methods, with heterogeneity statistics including Cochran's Q, I², and Tau², visualized as forest and funnel plots.
EvidenceFlow has a free listing. The owner can unlock the full profile with a paid launch for $5:
- Founder story (locked)
- Milestones (locked)
- Demo video (locked)
- Dofollow website link (locked)
Also on the bill
-
Act 1
Act 1:
InsiderFilings.infoSEC insider filings screener for Forms 3, 4 and 5
DR 7 no change since last check 1 votes. Log in to give InsiderFilings.info an encore vote -
Act 2
Act 2:
HackerTube AI
Curiosity, curated.
DR 11 +8 (up) since last check 0 votes. Log in to give HackerTube AI an encore vote -
Act 3
Act 3:
InnogathAI research workspace for cited reports, auto-generated diagrams, and branching knowledge pages
DR 5 no change since last check 0 votes. Log in to give Innogath an encore vote -
Act 4
Act 4:
Peptide TitansResearch peptides with independent third-party testing and lot-specific documentation
DR 16 +1 (up) since last check 0 votes. Log in to give Peptide Titans an encore vote
